@article{oai:repo.qst.go.jp:00047776,
 author = {Moriguchi, Sho and Yamada, Makiko and Takano, Harumasa and Nagashima, Tomohisa and Takahata, Keisuke and Yokokawa, Keita and Ito, Takehito and Ishii, Tatsuya and Kimura, Yasuyuki and Zhang, Ming-Rong and Mimura, Masaru and Suhara, Tetsuya and 森口 翔 and 山田 真希子 and 高野 晴成 and 永嶌 朋久 and 高畑 圭輔 and 横川 啓太 and 伊藤 岳人 and 石井 辰弥 and 木村 泰之 and 張 明栄 and 三村 將 and 須原 哲也},
 issue = {1},
 journal = {The American journal of psychiatry},
 month = {Sep},
 note = {The norepinephrine transporter has been suggested to play a crucial role in major depressive disorder. However, norepinephrine transporter availability in major depressive disorder and its role with clinical symptoms are not known. The authors tested norepinephrine transporter availability in patients with major depressive disorder with the aim to identify any associations between test results and clinical symptoms.},
 pages = {36--41},
 title = {Norepinephrine Transporter in Major Depressive Disorder: A PET Study.},
 volume = {174},
 year = {2016}
}